• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于炎症反应的评分系统可预测一线化疗前转移性胃癌患者的预后。

Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy.

机构信息

University of Campania 'Luigi Vanvitelli' - School of Medicine, Department of Precision Medicine, Division of Medical Oncology, Via Pansini n.5, 80131 Naples, Italy.

University of Campania 'Luigi Vanvitelli'- Division of GI Tract Surgical Oncology, Department of Surgical Sciences, Via Pansini n.5, 80131 Naples, Italy.

出版信息

Future Oncol. 2018 Oct;14(24):2493-2505. doi: 10.2217/fon-2018-0167. Epub 2018 Jul 3.

DOI:10.2217/fon-2018-0167
PMID:29969285
Abstract

AIM

Systemic inflammatory response affects survival of gastric cancer (GC) patients. This study was carried out to create a prognostic inflammatory-based score to predict survival in metastatic GC (mGC) before first-line chemotherapy.

MATERIALS & METHODS: We studied the prognostic value of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio in 151 patients with mGC at the diagnosis.

RESULTS

Median overall survival (OS) was significantly lower in patients with high NLR. Performance status 1-2 according to the Eastern Cooperative Oncology Group scale and NLR were predictors of shorter OS at multivariate analysis. Based on these results, we defined a prognostic OS score, showing a better median OS in favorable risk group.

CONCLUSION

Elevated pretreatment NLR and Eastern Cooperative Oncology Group are independent predictors of shorter OS in mGC patients before first-line chemotherapy.

摘要

目的

全身炎症反应会影响胃癌(GC)患者的生存。本研究旨在建立一种基于炎症的预后评分,以预测一线化疗前转移性 GC(mGC)患者的生存情况。

材料与方法

我们研究了 NLR 和血小板-淋巴细胞比值在 151 例 mGC 患者诊断时的预后价值。

结果

高 NLR 组的中位总生存期(OS)显著降低。根据东部肿瘤协作组(ECOG)量表,体力状态 1-2 分和 NLR 是多因素分析中 OS 较短的预测因素。基于这些结果,我们定义了一个预后 OS 评分,显示在低危组中有更好的中位 OS。

结论

在接受一线化疗前,mGC 患者的 NLR 升高和 ECOG 是 OS 较短的独立预测因素。

相似文献

1
Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy.基于炎症反应的评分系统可预测一线化疗前转移性胃癌患者的预后。
Future Oncol. 2018 Oct;14(24):2493-2505. doi: 10.2217/fon-2018-0167. Epub 2018 Jul 3.
2
Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在转移性胃癌患者中的预后意义
Medicine (Baltimore). 2020 Mar;99(10):e19405. doi: 10.1097/MD.0000000000019405.
3
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy.中性粒细胞与淋巴细胞比值升高可预测接受曲妥珠单抗联合化疗的晚期胃癌患者的生存情况。
Anticancer Res. 2018 May;38(5):3151-3156. doi: 10.21873/anticanres.12578.
4
Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy.中性粒细胞计数和基于炎症的格拉斯哥预后评分可预测晚期胃癌一线化疗患者的生存率。
Asian Pac J Cancer Prev. 2014;15(2):945-50. doi: 10.7314/apjcp.2014.15.2.945.
5
Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.术前中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对Ⅰ-Ⅱ期胃癌患者生存的预测作用
Chin J Cancer. 2016 Jun 24;35(1):57. doi: 10.1186/s40880-016-0122-2.
6
Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.术前炎症反应生物标志物在胃癌患者中的预后价值及预测模型的构建
J Transl Med. 2015 Feb 18;13:66. doi: 10.1186/s12967-015-0409-0.
7
Novel immunological and nutritional-based prognostic index for gastric cancer.新型基于免疫和营养的胃癌预后指数
World J Gastroenterol. 2015 May 21;21(19):5961-71. doi: 10.3748/wjg.v21.i19.5961.
8
Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.联合中性粒细胞/血小板/淋巴细胞/分化评分预测晚期胃癌的化疗敏感性。
BMC Cancer. 2018 May 2;18(1):515. doi: 10.1186/s12885-018-4414-6.
9
The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer.术前血糖与淋巴细胞比值对预测转移性胃癌患者生存的价值。
Future Oncol. 2023 Feb;19(4):315-325. doi: 10.2217/fon-2022-0579. Epub 2023 Mar 9.
10
Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer.不可切除性复发晚期胃癌化疗患者全身炎症反应生物标志物的评估
Oncology. 2016;90(6):321-6. doi: 10.1159/000446373. Epub 2016 May 26.

引用本文的文献

1
Prognostic significance of the pretreatment pan-immune-inflammation value in colorectal cancer patients: an updated meta-analysis.结直肠癌患者治疗前全免疫炎症值的预后意义:一项更新的荟萃分析。
Front Oncol. 2025 Jul 24;15:1599075. doi: 10.3389/fonc.2025.1599075. eCollection 2025.
2
Analysis of the treatment efficacy and prognostic factors of PD-1/PD-L1 inhibitors for advanced gastric or gastroesophageal junction cancer: a multicenter, retrospective clinical study.多中心回顾性临床研究:PD-1/PD-L1 抑制剂治疗晚期胃癌或胃食管结合部癌的疗效及预后因素分析。
Front Immunol. 2024 Oct 24;15:1468342. doi: 10.3389/fimmu.2024.1468342. eCollection 2024.
3
Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma.
系统性炎症生物标志物作为胃食管腺癌患者的预后工具。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17081-17091. doi: 10.1007/s00432-023-05424-4. Epub 2023 Sep 26.
4
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience.西方晚期胃癌分子亚型的临床意义:一项真实世界多中心经验。
Int J Mol Sci. 2023 Jan 3;24(1):813. doi: 10.3390/ijms24010813.
5
Effect of Self-Transcendence Theory Combined with Comprehensive Nursing Intervention under Tumor Nutrition Education on Symptom Improvement, Nutritional Status, and Positive Psychology of Elderly Patients with Gastric Cancer.自我超越理论联合肿瘤营养教育下综合护理干预对老年胃癌患者症状改善、营养状态及正性心理学的影响。
Contrast Media Mol Imaging. 2022 Jul 12;2022:6084732. doi: 10.1155/2022/6084732. eCollection 2022.
6
Elevated baseline circulating platelet-to-lymphocyte ratio and survival in initial stage Ⅳ gastric cancer patients: A meta-analysis.基线循环血小板与淋巴细胞比值升高与Ⅳ期胃癌患者的早期生存相关:一项荟萃分析。
PLoS One. 2022 Apr 18;17(4):e0265897. doi: 10.1371/journal.pone.0265897. eCollection 2022.
7
Utility of Pretreatment Blood Platelet-To-Lymphocyte Ratio in Prediction of Clinical Outcomes and Chemosensitivity in Patients with Advanced Gastric Cancer: A Meta-Analysis.术前血小板与淋巴细胞比值对晚期胃癌患者临床结局和化疗敏感性的预测价值:Meta 分析。
Med Sci Monit. 2022 Jan 31;28:e933449. doi: 10.12659/MSM.933449.
8
Biomarkers for Precision Treatment in Gastric Cancer.胃癌精准治疗的生物标志物
Visc Med. 2020 Oct;36(5):364-372. doi: 10.1159/000510489. Epub 2020 Sep 25.
9
Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection.根治性切除术后晚期胃癌外周血源性炎症标志物的临床意义
BMC Surg. 2020 Oct 2;20(1):219. doi: 10.1186/s12893-020-00884-8.
10
Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.血小板-淋巴细胞比值(PLR)在胃癌中的临床病理和预后意义:一项更新的荟萃分析。
World J Surg Oncol. 2020 Jul 30;18(1):191. doi: 10.1186/s12957-020-01952-2.